Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
allegedly, analyst, appeal, Article, Arzneimittel, authorisation, binomial, Biotech, BTIG, Cencora, chemical, CRL, cycle, detract, disagreement, element, enumerated, Essex, exhibit, fashion, herewith, hurt, inflow, lattice, lawsuit, learned, lending, mauturity, Membership, mg, nAMD, notification, NY, panel, presence, purport, quotation, regain, regaining, resubmission, run, Shanghai, Similary, sixteen, SPA, STADA, structure, text, textual, timeline, waived, Week, wider
Removed:
Australian, averaged, close, collaborator, comprised, confer, disposed, disrupted, Division, economically, EEA, GST, Junction, lapsed, leasehold, lifted, magnitude, missed, Monmouth, movement, ONSIU, ONSIW, ONSIZ, OTLKW, paramount, phased, productivity, recurrent, refrain, reimposed, remote, select, separation, situation, spending, titled, transferred, unusually, whichever, worsen
Filing tables
Filing exhibits
Related press release
OTLK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-211362, 333-216081, 333-223064, 333-229685, 333-234024, 333-236471, 333-238318, 333-254777, 333-262731 and 333-269770) on Form S-8 and (Nos. 333-222387, 333-223063, 333-254778 and 333-273979) on Form S-3 of our report dated December 22, 2023, with respect to the consolidated financial statements of Outlook Therapeutics, Inc.
​
/s/ KPMG LLP
Philadelphia, Pennsylvania
December 22, 2023